subject area of
- Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries. Journal Articles
- Biosimilars for psoriasis: clinical studies to determine similarity Journal Articles
- Biosimilars for psoriasis: preclinical analytical assessment to determine similarity Journal Articles
- Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice Journal Articles
- Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective Journal Articles
- PANLAR consensus statement on biosimilars Journal Articles
- Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis Journal Articles
- Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada Journal Articles
- Survival of the fittest Journal Articles